American International Group, Inc. Lineage Cell Therapeutics, Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.86 - $1.48 $483 - $831	-562 Reduced 0.85%	65,397 $96,000
Q4 2023 Feb 13, 2024	BUY	$0.91 - $1.35 $1,415 - $2,099	1,555 Added 2.41%	65,959 $71,000
Q3 2023 Nov 13, 2023	BUY	$1.16 - $1.53 $2,656 - $3,503	2,290 Added 3.69%	64,404 $75,000
Q2 2023 Aug 04, 2023	BUY	$1.26 - $1.53 $78,263 - $95,034	62,114 New	62,114 $87,000
Q2 2022 Aug 12, 2022	SELL	$1.12 - $1.61 $69,736 - $100,246	-62,265 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.21 - $2.48 $5,302 - $10,867	-4,382 Reduced 6.57%	62,265 $96,000
Q4 2021 Feb 11, 2022	SELL	$1.84 - $2.68 $3,670 - $5,346	-1,995 Reduced 2.91%	66,647 $163,000
Q3 2021 Nov 12, 2021	BUY	$2.26 - $2.86 $1,568 - $1,984	694 Added 1.02%	68,642 $173,000
Q2 2021 Aug 13, 2021	BUY	$2.17 - $3.0 $147,447 - $203,844	67,948 New	67,948 $194,000
Q2 2020 Aug 12, 2020	SELL	$0.71 - $1.18 $45,455 - $75,545	-64,022 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$0.6 - $1.58 $2,218 - $5,842	-3,698 Reduced 5.46%	64,022 $53,000
Q4 2019 Feb 05, 2020	SELL	$0.54 - $1.01 $307 - $575	-570 Reduced 0.83%	67,720 $60,000
Q3 2019 Nov 08, 2019	BUY	$0.85 - $1.24 $58,046 - $84,679	68,290 New	68,290 $67,000

121

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.